Risk for PML in Multiple Sclerosis Predicted With Anti-JCV Antibody Index
While an efficacious treatment for relapsing MS, natalizumab is associated with risk of developing progressive multifocal leukoencephalopathy.
A new warning has been added to the multiple sclerosis drug Lemtrada (alemtuzumab) after rare reports of patients suffering strokes and tears in the lining of the arteries in the ...
Rates of multiple sclerosis relapse decrease during pregnancy but increase postpartum.
The rate and frequency of relapse vary for patients with multiple sclerosis, and many report not visiting a health care provider during relapse.